TIGIT in Patients With Chronic Myeloid Leukemia
NCT04818619 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 65
Last updated 2021-03-29
Summary
To expresse TIGIT in NK Cells in Patients with Chronic Myeloid Leukemia
Conditions
- Chronic Myeloid Leukemia
Interventions
- DIAGNOSTIC_TEST
-
flow cytometry test
Blood samples will be stained with TIGIT by flow cytometry test
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-30
- Primary Completion
- 2022-04-30
- Completion
- 2022-12-31
More Related Trials
-
Immune Profiling for Cancer Immunotherapy Response
NCT06116032 ·Status: RECRUITING
-
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
NCT01915992 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
NCT02203825 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
NCT03325036 ·Status: COMPLETED
-
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 ·Status: COMPLETED
-
Study of Blood Immune Cells in Cancer Patients Compared to Controls
NCT01312701 ·Status: UNKNOWN
-
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
NCT00173290 ·Status: UNKNOWN
-
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
NCT00177190 ·Status: COMPLETED
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
NCT04871165 ·Status: UNKNOWN
-
A Study in Adult Subjects With Select Advanced Solid Tumors
NCT02583165 ·Status: COMPLETED ·Phase: PHASE1
-
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
NCT00863395 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
NCT00851032 ·Status: UNKNOWN
-
The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human
NCT04298502 ·Status: UNKNOWN
-
Neoantigen-expanded Autologous Immune Cell Therapy
NCT05020119 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
NCT00430053 ·Status: COMPLETED
-
Age-matched Reference Values for Circulating Natural Killer T-like Cells
NCT06450743 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
NCT00909558 ·Status: SUSPENDED ·Phase: PHASE1
-
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
NCT05995821 ·Status: RECRUITING
-
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
NCT04408950 ·Status: COMPLETED
-
Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
NCT01884168 ·Status: COMPLETED
-
Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors
NCT03989050 ·Status: WITHDRAWN
-
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
NCT00177268 ·Status: RECRUITING
-
Study of the Immune Response After Vaccination in Multiple Myeloma Patients
NCT02294487 ·Status: COMPLETED